Latest ROE for Baird Medical Investment Holdings Limited: -47.26% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-47.26%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for BDMD is -47.26%. That is below the sector sector average of -4.03%. Investors often review this figure alongside Baird Medical Investment Holdings Limited's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, BDMD currently prints -47.26% for ROE, while the sector average sits near -4.03%. That is roughly 1074.2% below the sector mean. Large gaps often invite a closer look at Baird Medical Investment Holdings Limited's growth, margins, and balance sheet.
Return on Equity shows how effectively Baird Medical Investment Holdings Limited converts resources into returns. At -47.26%, BDMD may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting BDMD's ROE (-47.26%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.